Literature DB >> 21912943

Parallel-tracking bottom-up approaches within chronic disease prevention programmes.

Glenn Laverack1.   

Abstract

Mesh：

Year:  2012        PMID： 21912943     DOI： 10.1007/s00038-011-0299-8

Source DB:  PubMed          Journal:  Int J Public Health        ISSN： 1661-8556            Impact factor:   3.380


× No keyword cloud information.
  4 in total

1.  A planning framework for community empowerment goals within health promotion.

Authors:  G Laverack; R Labonte
Journal:  Health Policy Plan       Date:  2000-09       Impact factor: 3.344

2.  Cracking the nut of health equity: top down and bottom up pressure for action on the social determinants of health.

Authors:  Fran Baum
Journal:  Promot Educ       Date:  2007

3.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245
  4 in total
  2 in total

1.  An evidence-based framework on community-centred approaches for health: England, UK.

Authors:  Jane South; Anne-Marie Bagnall; Jude A Stansfield; Kris J Southby; Pritti Mehta
Journal:  Health Promot Int       Date:  2019-04-01       Impact factor: 2.483

2.  Capacity Building in Community Stakeholder Groups for Increasing Physical Activity: Results of a Qualitative Study in Two German Communities.

Authors:  Julika Loss; Nicola Brew-Sam; Boris Metz; Helmut Strobl; Alexandra Sauter; Susanne Tittlbach
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.